| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Financial Officer | EVP, Chief Financial Officer | Chief Financial Officer
1 company
Schneyer Mark C. is an EVP, Chief Financial Officer at ACADIA PHARMACEUTICALS INC. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $1.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 19, 2024 | ACAD Acadia Pharmaceuticals Inc | EVP, Chief Financial Officer | Sale+OE | 10,259 | $16.81 | $172,453.79 | -16.1% | +21.8% | +42.5% | |
| Aug 19, 2024 | ACAD Acadia Pharmaceuticals Inc | EVP, Chief Financial Officer | Sell | 9,733 | $15.28 | $148,720.24 | -18.2% | +8.1% | +58.4% | |
| Jun 10, 2024 | ACAD Acadia Pharmaceuticals Inc | EVP, Chief Financial Officer | Sale+OE | 975 | $14.79 | $14,420.25 | -2.7% | +6.0% | +49.2% | |
| May 2, 2024 | ACAD Acadia Pharmaceuticals Inc | EVP, Chief Financial Officer | Sale+OE | 3,503 | $16.94 | $59,340.82 | -9.9% | +11.4% | -12.7% | |
| Apr 8, 2024 | ACAD Acadia Pharmaceuticals Inc | EVP, Chief Financial Officer | Sale+OE | 2,716 | $17.87 | $48,534.92 | -8.6% | -8.3% | -20.8% | |
| Mar 27, 2024 | ACAD Acadia Pharmaceuticals Inc | EVP, Chief Financial Officer | Sell | 5,434 | $17.90 | $97,268.60 | -17.2% | -14.3% | -5.5% | |
| Feb 26, 2024 | ACAD Acadia Pharmaceuticals Inc | EVP, Chief Financial Officer | Sale+OE | 772 | $24.67 | $19,045.24 | -3.5% | -41.7% | -26.6% | |
| Nov 20, 2023 | ACAD Acadia Pharmaceuticals Inc | EVP, Chief Financial Officer | Sale+OE | 5,108 | $22.64 | $115,645.12 | -20.0% | +8.4% | -29.3% | |
| Aug 21, 2023 | ACAD Acadia Pharmaceuticals Inc | EVP, Chief Financial Officer | Sell | 10,000 | $29.00 | $289,970.00 | -38.9% | -24.4% | -48.6% | |
| Jun 8, 2023 | ACAD Acadia Pharmaceuticals Inc | EVP, Chief Financial Officer | Sale+OE | 974 | $25.02 | $24,369.48 | -4.1% | +8.1% | -40.7% |